clinical trial · NCT06827990
GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections
W.L.Gore & Associates·N/A·recruiting·n = 112
Aortic DissectionGORE® Ascending Stent Graft (ASG device)
brief summary
To assess the safety and effectiveness of the ASG device in the treatment of de novo Type A aortic dissections.
started
Sep 22, 2025
primary completion
Sep 1, 2030
completion
Sep 1, 2031
last updated
Apr 14, 2026
detailed description
This pivotal investigation is a prospective, multicenter, non-randomized, single-arm study to evaluate the safety and effectiveness of the ASG device for the treatment of de novo Type A aortic dissections in patients considered to be high-risk for open surgical repair.
official title
Evaluation of the GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol